Cambrex Investing $30M, Adding 78 Jobs at High Point Pharma Facility | North Carolina Biotechnology Center

Cambrex Corp., a contract manufacturer of small-molecule therapeutics with major facilities in High Point and Durham, plans to invest another $30 million and hire 78 more employees to expand the production capabilities of its High Point campus.

Related Keywords

Guilford County ,North Carolina ,United States ,Paullo ,Lombardia ,Italy ,Milan ,Piedmont ,Piemonte ,United Kingdom ,City Of High Point ,Karlskoga ,Orebro ,Sweden ,Canada ,Germany ,Wiesbaden ,Hessen ,Charles City ,Iowa ,Estonia ,Colorado ,Longmont ,Tallinn ,Harjumaa ,Edinburgh ,City Of ,America ,Scotland ,American ,Machelle Baker Sanders ,Cambrex Durham ,Nancy Johnston ,Roy Cooper ,Thomas Loewald ,Inc Fund ,Us Drug Enforcement Administration ,High Point Economic Development Corporation ,Cambrex Corp ,Carolina Biotechnology Center Piedmont Triad Office ,National Manufacturing Day ,Avista Pharma Solutions ,Carolina Department Of Commerce ,Carolina Fund ,Economic Development Partnership Of North Carolina ,Guilford County Economic Development Alliance ,Carolina Community College System ,High Point ,Governor Roy Cooper ,East Rutherford ,Enforcement Administration ,North Carolina Commerce Secretary Machelle Baker ,Piedmont Triad ,North Carolina Biotechnology Center ,One North Carolina Fund ,Fall One ,North America ,North American ,United Statesa ,Its European ,North Carolina Department ,Economic Development Partnership ,North Carolina General Assembly ,North Carolina Community College System ,